Letters to HCPs
Important information for Healthcare Professionals
Direct Healthcare Professional Communication on approved dosing regimens for Accord Bivalirudin for Percutaneous Coronary Intervention (PCI), following reports of inappropriate use
This letter will provide guidance on the dosing regimen, administration instructions, safety concerns and suspected adverse reactions to HCPs for patients undergoing Percutaneous Coronary Intervention (PCI).
For Healthcare Professionals